Completed NA INTERVENTIONAL 2-arm NCT01837238

Efficacy of Beta-Hydroxy-Beta-Methylbutyrate (HMB) Supplementation in Hemodialysis Patients

Sponsor: University of Illinois at Urbana-Champaign

Conditions Chronic Kidney Disease Complication of Dialysis End Stage Renal Disease Muscle Loss

Updated 5 times since 2017 Last updated: Oct 28, 2016 Started: Nov 30, 2012 Primary completion: May 31, 2016 Completion: May 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01837238, this NA trial focuses on Chronic Kidney Disease and Complication of Dialysis and remains completed. Sponsored by University of Illinois at Urbana-Champaign, it has been updated 5 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Nov 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Illinois at Urbana-Champaign

Data source: University of Illinois at Urbana-Champaign

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Urbana, United States